Literature DB >> 28645803

GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome.

Inna Y Gong1, Shaun G Goodman2, David Brieger3, Chris P Gale4, Derek P Chew5, Robert C Welsh6, Thao Huynh7, J Paul DeYoung8, Carolyn Baer9, Gabor T Gyenes6, Jacob A Udell10, Keith A A Fox11, Andrew T Yan12.   

Abstract

BACKGROUND: Although there are sex differences in management and outcome of acute coronary syndromes (ACS), sex is not a component of Global Registry of Acute Coronary Events (GRACE) risk score (RS) for in-hospital mortality prediction. We sought to determine the prognostic utility of GRACE RS in men and women, and whether its predictive accuracy would be augmented through sex-based modification of its components.
METHODS: Canadian men and women enrolled in GRACE and Canadian Registry of Acute Coronary Events were stratified as ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation ACS (NSTE-ACS). GRACE RS was calculated as per original model. Discrimination and calibration were evaluated using the c-statistic and Hosmer-Lemeshow goodness-of-fit test, respectively. Multivariable logistic regression was undertaken to assess potential interactions of sex with GRACE RS components.
RESULTS: For the overall cohort (n=14,422), unadjusted in-hospital mortality rate was higher in women than men (4.5% vs. 3.0%, p<0.001). Overall, GRACE RS c-statistic and goodness-of-fit test p-value were 0.85 (95% CI 0.83-0.87) and 0.11, respectively. While the RS had excellent discrimination for all subgroups (c-statistics >0.80), discrimination was lower for women compared to men with STEMI [0.80 (0.75-0.84) vs. 0.86 (0.82-0.89), respectively, p<0.05]. The goodness-of-fit test showed good calibration for women (p=0.86), but suboptimal for men (p=0.031). No significant interaction was evident between sex and RS components (all p>0.25).
CONCLUSIONS: The GRACE RS is a valid predictor of in-hospital mortality for both men and women with ACS. The lack of interaction between sex and RS components suggests that sex-based modification is not required.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute coronary syndrome; GRACE risk score; Risk stratification; Sex differences; Validation

Mesh:

Year:  2017        PMID: 28645803     DOI: 10.1016/j.ijcard.2017.06.055

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Comparison of GRACE and TIMI risk scores in the prediction of in-hospital and long-term outcomes among East Asian non-ST-elevation myocardial infarction patients.

Authors:  Lu Yanqiao; Lan Shen; Miao Yutong; Shen Linghong; He Ben
Journal:  BMC Cardiovasc Disord       Date:  2022-01-07       Impact factor: 2.298

2.  External validation of the GRACE risk score and the risk-treatment paradox in patients with acute coronary syndrome.

Authors:  Niels M R van der Sangen; Jaouad Azzahhafi; Dean R P P Chan Pin Yin; Joyce Peper; Senna Rayhi; Ronald J Walhout; Melvyn Tjon Joe Gin; Deborah M Nicastia; Jorina Langerveld; Georgios J Vlachojannis; Rutger J van Bommel; Yolande Appelman; José P S Henriques; Jurriën M Ten Berg; Wouter J Kikkert
Journal:  Open Heart       Date:  2022-03

3.  Value of GRACE and SYNTAX scores for predicting the prognosis of patients with non-ST elevation acute coronary syndrome.

Authors:  Xiao-Feng Wang; Ming Zhao; Fei Liu; Guo-Rong Sun
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337

4.  Systematic review and meta-analysis of prognostic models in Southeast Asian populations with acute myocardial infarction.

Authors:  Sophia Rasheeqa Ismail; Muhamad Khairul Nazrin Khalil; Mohd Shawal Faizal Mohamad; Shamsul Azhar Shah
Journal:  Front Cardiovasc Med       Date:  2022-07-26

5.  The GRACE risk score in patients with ST-segment elevation myocardial infarction and concomitant COVID-19.

Authors:  Mariusz Wójcik; Jakub Karpiak; Lech Zaręba; Andrzej Przybylski
Journal:  Arch Med Sci Atheroscler Dis       Date:  2022-08-10

6.  Serum Calprotectin Levels and Outcome Following Percutaneous Coronary Intervention in Patients with Diabetes and Acute Coronary Syndrome.

Authors:  Chengji Wang; Yu Kong; Yuanyuan Ding; Jingzhi Sun; Tao Chen
Journal:  Med Sci Monit       Date:  2019-12-13

7.  Prognostic value of serum calprotectin level in elderly diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: A Cohort study.

Authors:  Wutang Zhang; Yongmei Kong; Lizhi Wang; Lizhong Song; Lijuan Tan; Xiaobo Xue
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.